At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 36 enrolled
Drug / intervention
SinuSys Dilation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
SinuSys Patency of Maxillary Sinus Ostia Study
In Brief
A Phase 1 clinical trial evaluating SinuSys Dilation System for Sinusitis. Completed, enrolled 36 participants across 5 sites in 3 countries.
Detailed Summary
The purpose of this study is to assess safety and performance of the SinuSys Dilation System for dilation of the maxillary sinus ostium.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSinusitis
CountriesCanada, United Kingdom, United States
Collaborators--
Timeline
Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2012
First PostedJun 2012
Primary CompletionJun 2013
Study CompletionSep 2014
TodayJul 2026
First PostedJun 19, 2012
Enrollment StartApr 1, 2012
Primary CompletionJun 1, 2013
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 14.0 years ago
Interventions
SinuSys Dilation Systemdevice
Sinuplasty